The multifarious, multireplicon Burkholderia cepacia complex

被引:665
作者
Mahenthiralingam, E
Urban, TA
Goldberg, JB [1 ]
机构
[1] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA
[2] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales
关键词
D O I
10.1038/nrmicro1085
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but phenotypically similar bacteria that are divided into at least nine species. Bcc bacteria are found throughout the environment, where they can have both beneficial and detrimental effects on plants and some members can also degrade natural and man-made pollutants. Bcc bacteria are now recognized as important opportunistic pathogens that can cause variable lung infections in cystic fibrosis patients, which result in asymptomatic carriage, chronic infection or 'cepacia syndrome', which is characterized by a rapid decline in lung function that can include invasive disease. Here we highlight the unique characteristics of the Bcc, focusing on the factors that determine virulence.
引用
收藏
页码:144 / 156
页数:13
相关论文
共 143 条
[1]   OUTER-MEMBRANE PERMEABILITY IN PSEUDOMONAS-CEPACIA - DIMINISHED PORIN CONTENT IN A BETA-LACTAM-RESISTANT MUTANT AND IN RESISTANT CYSTIC-FIBROSIS ISOLATES [J].
ARONOFF, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1636-1639
[2]   The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia [J].
Baldwin, A ;
Sokol, PA ;
Parkhill, J ;
Mahenthiralingam, E .
INFECTION AND IMMUNITY, 2004, 72 (03) :1537-1547
[3]   The treatment of respiratory pseudomonas infection in cystic fibrosis - What drug and which way? [J].
Banerjee, D ;
Stableforth, D .
DRUGS, 2000, 60 (05) :1053-1064
[4]   RESPONSE OF PSEUDOMONAS-CEPACIA TO BETA-LACTAM ANTIBIOTICS - UTILIZATION OF PENICILLIN-G AS THE CARBON SOURCE [J].
BECKMAN, W ;
LESSIE, TG .
JOURNAL OF BACTERIOLOGY, 1979, 140 (03) :1126-1128
[5]   Comparative analysis of plant and animal models for characterization of Burkholdetia cepacia virulence [J].
Bernier, SP ;
Silo-Suh, L ;
Woods, DE ;
Ohman, DE ;
Sokol, PA .
INFECTION AND IMMUNITY, 2003, 71 (09) :5306-5313
[6]   Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy:: Genomovar status and distribution of traits related to virulence and transmissibility [J].
Bevivino, A ;
Dalmastri, C ;
Tabacchioni, S ;
Chiarini, L ;
Belli, ML ;
Piana, S ;
Materazzo, A ;
Vandamme, P ;
Manno, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :846-851
[7]   Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis [J].
Biddick, R ;
Spilker, T ;
Martin, A ;
LiPuma, JJ .
FEMS MICROBIOLOGY LETTERS, 2003, 228 (01) :57-62
[8]  
BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115
[9]   CHLORAMPHENICOL RESISTANCE IN PSEUDOMONAS-CEPACIA BECAUSE OF DECREASED PERMEABILITY [J].
BURNS, JL ;
HEDIN, LA ;
LIEN, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :136-141
[10]   Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia [J].
Burns, JL ;
Jonas, M ;
Chi, EY ;
Clark, DK ;
Berger, A ;
Griffith, A .
INFECTION AND IMMUNITY, 1996, 64 (10) :4054-4059